CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-05 | BENZENO SHARON Chief Commercial Ofc Imm Med | Sale | −3,065 | $6.99 | $21K | 392,723 |
| 2025-03-05 | PISKEL KYLE Chief Financial Officer | Sale | −3,103 | $6.97 | $22K | 276,227 |
| 2025-03-05 | PISKEL KYLE Chief Financial Officer | Sale | −253 | $6.98 | $2K | 275,974 |
| 2025-03-05 | PISKEL KYLE Chief Financial Officer | Sale | −6,964 | $6.99 | $49K | 269,010 |
| 2025-03-05 | RUBINSTEIN JULIE President and COO | Sale | −40,044 | $6.98 | $280K | 607,710 |
| 2025-03-05 | RUBINSTEIN JULIE President and COO | Sale | −19,461 | $6.99 | $136K | 588,249 |
| 2025-03-05 | ROBINS HARLAN S Chief Scientific Officer | Sale | −40,603 | $6.98 | $283K | 1,335,577 |
| 2025-03-05 | ROBINS HARLAN S Chief Scientific Officer | Sale | −56,053 | $6.99 | $392K | 1,279,524 |
| 2025-03-05 | ROBINS CHAD M CEO and Chairman | Sale | −81,206 | $6.98 | $567K | 2,850,495 |
| 2025-03-05 | ROBINS CHAD M CEO and Chairman | Sale | −36,145 | $6.99 | $253K | 2,814,350 |
| 2025-03-05 | ROBINS CHAD M CEO and Chairman | Grant or award | +247,117 | 3,061,467 | ||
| 2025-03-04 | LO FRANCIS Chief People Officer | Grant or award | +99,976 | 353,721 | ||
| 2025-03-04 | LO FRANCIS Chief People Officer | Grant or award · Stock Option (right to buy) | +150,024 | 150,024 | ||
| 2025-03-04 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Grant or award | +119,971 | 373,261 | ||
| 2025-03-04 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Grant or award · Stock Option (right to buy) | +180,029 | 180,029 | ||
| 2025-03-04 | BENZENO SHARON Chief Commercial Ofc Imm Med | Grant or award | +109,973 | 437,388 | ||
| 2025-03-04 | BENZENO SHARON Chief Commercial Ofc Imm Med | Grant or award · Stock Option (right to buy) | +165,027 | 165,027 | ||
| 2025-03-04 | PISKEL KYLE Chief Financial Officer | Grant or award | +125,000 | 279,330 | ||
| 2025-03-04 | RUBINSTEIN JULIE President and COO | Grant or award | +175,000 | 647,754 | ||
| 2025-03-04 | ROBINS HARLAN S Chief Scientific Officer | Grant or award | +355,000 | 1,376,180 |
Page 27 of 120 · 2,386 trades